Results 261 to 270 of about 5,337,944 (374)
Treatment of ovarian cancer: From the past to the new era (Review). [PDF]
Oncol LettAlrosan K +7 more
europepmc +1 more source
Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer. [PDF]
, 1994 Ichiro Yoshino +4 more
openalex +1 more source
Advanced Science, EarlyView.This review compares clinical outcomes, translational progress, and global funding trends across cancer phototherapies—photodynamic, photothermal, and photoimmunotherapy—and conventional immunotherapy. It highlights differences in treatment efficacy, clinical trial status, financial investment, and regulatory challenges, providing a comprehensive ...
Deepak S. Chauhan +6 more
wiley +1 more source
Elucidating the role of fatty acid reprogramming in ovarian cancer: insights cross-talk between blood, subcutaneous fat, and ovarian cancer tissues. [PDF]
Front OncolZhong X +8 more
europepmc +1 more source
Advanced Science, EarlyView.This study identifies MTCH2 as a crucial regulator of ferroptosis in colorectal cancer (CRC) progression. High expression of MTCH2 is correlated with poor prognosis in CRC patients. Furthermore, MTCH2 depletion induces ferroptosis to suppress CRC liver metastasis via the E2F4/TFRC axis and sensitizes tumors to sorafenib treatment, supporting MTCH2 as a
Pu Xing +18 more
wiley +1 more source
BRCA1 expression in ovarian cancer and its relationship with clinicopathological characteristics and prognosis. [PDF]
Sci RepPan C, Xu S, Li L, Lin A.
europepmc +1 more source
S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3
, 1994 Jianhua Zheng
openalex +2 more sources
Epithelial ovarian cancer: a cytokine propelled disease? [PDF]
, 1991 S. Malik, Frances R. Balkwill
openalex +1 more source